HPV Vaccination Completion and Compliance with Recommended Dosing Intervals Among Female and Male Adolescents in an Inner-City Community Health Center

Wilson, Rula M.; Brown, Diane R.; Carmody, Dennis P.; Fogarty, Sushanna

doi:10.1007/s10900-014-9950-7

Cited by 14 publications

(11 citation statements)

References 31 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…11,15–17 Research in the Greater Newark area revealed that only 21% of Latino adolescents (10–20 years old) have initiated the HPV vaccine, 18 and 8% have completed the three-dose series. 19…”

Section: Introductionmentioning

confidence: 99%

Knowledge and Attitudes Toward Human Papillomavirus Vaccination Among Latina Mothers of South American and Caribbean Descent in the Eastern US

et al. 2019

Self Cite

View full text Add to dashboard Cite

Purpose: The purpose of this study was to examine knowledge, attitudes, barriers, and facilitators for human papillomavirus (HPV) vaccination among Latina mothers of HPV vaccine-eligible children in low-income urban areas, as well as useful strategies to improve HPV vaccination. Methods: The study included 132 Latina mothers of HPV vaccine-eligible children, interviewed in 14 focus groups. Using semi-structured discussions, mothers were asked about their knowledge about HPV infection and vaccine, views toward HPV vaccination, barriers for HPV vaccine initiation as well as completion, and opinions on strategies to improve HPV vaccination. Results: Only 55% of mothers reported having ever heard of the HPV vaccine, 27% of mothers indicated initiating the HPV vaccine, and 14% indicated completing the multi-dose series. Mothers generally lacked knowledge about HPV infection and vaccination, with varying degrees by Latino descent. Health care provider (HCP) recommendation was the strongest barrier/facilitator for HPV vaccination. Useful strategies to improve HPV vaccine initiation and completion that the mothers suggested included strong recommendation from HCPs and addressing side effects and safety concerns. Other useful strategies included community and school-based approaches and the use of text messaging and smartphone technology to educate mothers and send vaccine reminders. Conclusion: The findings provide insight for the development of interventions targeting low-income Latina mothers and the need to improve HCP communication on HPV vaccination.

show abstract

Section: Introductionmentioning

confidence: 99%

Knowledge and Attitudes Toward Human Papillomavirus Vaccination Among Latina Mothers of South American and Caribbean Descent in the Eastern US

et al. 2019

Self Cite

View full text Add to dashboard Cite

show abstract

“…In order to improve HPV vaccination, it is essential to understand current patterns of HPV vaccination. While previous research has primarily focused on HPV vaccine initiation and completion among adolescent girls, the adherence of recommended HPV dose schedules has not been well assessed [17] , [18] , [19] , [20] , [21] , [22] . The objectives of this study were to: (1) examine HPV vaccine completion and dose adherence among commercially insured females who were aged 9 through 26 years old and had initiated HPV vaccination; (2) identify factors associated with HPV vaccine completion and dose adherence among these females.…”

Section: Introductionmentioning

confidence: 99%

HPV vaccine completion and dose adherence among commercially insured females aged 9 through 26 years in the US

Liu

Kong

2016

Papillomavirus Research

View full text Add to dashboard Cite

Background Although HPV vaccination has been recommended for use in girls and young women since 2007, HPV vaccine uptake is low in the US. Methods We conducted a retrospective cohort study using the 2008–2011 MarketScan data to examine HPV vaccine completion and dose adherence among commercially insured females aged 9–26 years. We performed multivariable logistic regression models to examine factors related to HPV vaccine completion and HPV vaccine dose adherence. Results Among 378,484 females aged 9–26 years who initiated HPV vaccination, only 29.4% completed HPV vaccination. Compared with females receiving vaccines from primary care providers, those receiving vaccines from OB/GYN providers were more likely to complete the vaccine series. Age at HPV vaccine initiation, health insurance plan, seasonal pattern, and flu vaccination were also significantly associated with vaccine completion. Among 111,286 females who completed HPV vaccination, 62.4% received all doses within 30 days of the recommended schedules. Similar factors relating to HPV vaccine completion were consistently associated with HPV vaccine dose adherence. However, younger age (<22 years) and receipt of flu vaccine were negatively related to HPV vaccine dose adherence. Conclusions Intervention programs to improve HPV vaccine reminding system and reduce logistic barriers for both physicians and patients are warranted.

show abstract

“…As an aside, completion of full human papillomavirus (HPV) vaccination is subject to age, rural vs. urban location, parental hesitancy/refusal and cultural factors [37,38]. In this example, which utilizes a very effective agent, effectiveness at the population level is limited by these barriers to utilization so that the role of the process assumes great importance even with a very effective vaccination tool.…”

Section: Collecting Evidence To Examine Screening Effectiveness—pementioning

confidence: 99%

Ten Important Considerations for Ovarian Cancer Screening

Pavlik

2017

Diagnostics

View full text Add to dashboard Cite

The unique intricacies of ovarian cancer screening and perspectives of different screening methods are presented as ten considerations that are examined. Included in these considerations are: (1) Deciding on the number of individuals to be screened; (2) Anticipating screening group reductions due to death; (3) Deciding on the duration and frequency of screening; (4) Deciding on an appropriate follow-up period after screening; (5) Deciding on time to surgery when malignancy is suspected; (6) Deciding on how screen-detected ovarian cancers are treated and by whom; (7) Deciding on how to treat the data of enrolled participants; (8) Deciding on the most appropriate way to assign disease-specific death; (9) Deciding how to avoid biases caused by enrollments that attract participants with late-stage disease who are either symptomatic or disposed by factors that are genetic, environmental or social; and (10) Deciding whether the screening tool or a screening process is being tested. These considerations are presented in depth along with illustrations of how they impact the outcomes of ovarian cancer screening. The considerations presented provide alternative explanations of effects that have an important bearing on interpreting ovarian screening outcomes.

show abstract

HPV Vaccination Completion and Compliance with Recommended Dosing Intervals Among Female and Male Adolescents in an Inner-City Community Health Center

Cited by 14 publications

References 31 publications

Knowledge and Attitudes Toward Human Papillomavirus Vaccination Among Latina Mothers of South American and Caribbean Descent in the Eastern US

Knowledge and Attitudes Toward Human Papillomavirus Vaccination Among Latina Mothers of South American and Caribbean Descent in the Eastern US

HPV vaccine completion and dose adherence among commercially insured females aged 9 through 26 years in the US

Ten Important Considerations for Ovarian Cancer Screening

Contact Info

Product

Resources

About